Showing 1 - 10 of 22
Persistent link: https://www.econbiz.de/10009301233
Persistent link: https://www.econbiz.de/10010350162
Persistent link: https://www.econbiz.de/10003844865
Persistent link: https://www.econbiz.de/10003269328
Background: Breast cancer (BC) is largely prevalent worldwide. HER2-positive BC account for roughly 20-25% of all BC cases and has an overall survival lower than other BC. Innovation on BC therapeutics is a constant, but novel therapies have higher costs. Therefore, cost-effectiveness research...
Persistent link: https://www.econbiz.de/10014489917
Persistent link: https://www.econbiz.de/10014381129
Persistent link: https://www.econbiz.de/10009301224
Persistent link: https://www.econbiz.de/10009301244
Persistent link: https://www.econbiz.de/10010350475
Persistent link: https://www.econbiz.de/10003841080